Literature DB >> 25579847

Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders.

Rodrigo B Mansur1, Elisa Brietzke2, Roger S McIntyre3.   

Abstract

Obesity and mood disorders are highly prevalent and co-morbid. Epidemiological studies have highlighted the public health relevance of this association, insofar as both conditions and its co-occurrence are associated with a staggering illness-associated burden. Accumulating evidence indicates that obesity and mood disorders are intrinsically linked and share a series of clinical, neurobiological, genetic and environmental factors. The relationship of these conditions has been described as convergent and bidirectional; and some authors have attempted to describe a specific subtype of mood disorders characterized by a higher incidence of obesity and metabolic problems. However, the nature of this association remains poorly understood. There are significant inconsistencies in the studies evaluating metabolic and mood disorders; and, as a result, several questions persist about the validity and the generalizability of the findings. An important limitation in this area of research is the noteworthy phenotypic and pathophysiological heterogeneity of metabolic and mood disorders. Although clinically useful, categorical classifications in both conditions have limited heuristic value and its use hinders a more comprehensive understanding of the association between metabolic and mood disorders. A recent trend in psychiatry is to move toward a domain specific approach, wherein psychopathology constructs are agnostic to DSM-defined diagnostic categories and, instead, there is an effort to categorize domains based on pathogenic substrates, as proposed by the National Institute of Mental Health (NIMH) Research Domain Criteria Project (RDoC). Moreover, the substrates subserving psychopathology seems to be unspecific and extend into other medical illnesses that share in common brain consequences, which includes metabolic disorders. Overall, accumulating evidence indicates that there is a consistent association of multiple abnormalities in neuropsychological constructs, as well as correspondent brain abnormalities, with broad-based metabolic dysfunction, suggesting, therefore, that the existence of a "metabolic-mood syndrome" is possible. Nonetheless, empirical evidence is necessary to support and develop this concept. Future research should focus on dimensional constructs and employ integrative, multidisciplinary and multimodal approaches.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Diabetes mellitus; Major depressive disorder; Metabolic syndrome; Metabolism; Mood disorders; Obesity; RDoC; Research domain criteria; Subtypes

Mesh:

Year:  2015        PMID: 25579847     DOI: 10.1016/j.neubiorev.2014.12.017

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  69 in total

1.  Opposing effects of S-equol supplementation on metabolic and behavioral parameters in mice fed a high-fat diet.

Authors:  Erin N Bax; Karlee E Cochran; Jiude Mao; Charles E Wiedmeyer; Cheryl S Rosenfeld
Journal:  Nutr Res       Date:  2018-12-21       Impact factor: 3.315

Review 2.  Mood-related central and peripheral clocks.

Authors:  Kyle D Ketchesin; Darius Becker-Krail; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2018-11-29       Impact factor: 3.386

3.  Spirituality/Religiosity (SpR), Leisure-Time Physical Activity, and Sedentary Behaviour in Students at a Catholic University.

Authors:  Edward K Waters; Zelda Doyle; Ellen Finlay
Journal:  J Relig Health       Date:  2018-06

4.  Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes.

Authors:  Rodrigo B Mansur; Gabriel R Fries; Mehala Subramaniapillai; Sophia Frangou; Fernanda G De Felice; Natalie Rasgon; Bruce McEwen; Elisa Brietzke; Roger S McIntyre
Journal:  J Psychiatr Res       Date:  2018-10-27       Impact factor: 4.791

5.  The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders.

Authors:  Rodrigo B Mansur; Gabriel R Fries; Alisson P Trevizol; Mehala Subramaniapillai; Julie Lovshin; Kangguang Lin; Maj Vinberg; Roger C Ho; Elisa Brietzke; Roger S McIntyre
Journal:  Eur Neuropsychopharmacol       Date:  2018-11-06       Impact factor: 4.600

6.  The effects of roux en y gastric bypass surgery on neurobehavioral symptom domains associated with severe obesity.

Authors:  Dominique Musselman; Neeta Shenvi; Amita Manatunga; Andrew H Miller; Edward Lin; Nana Gletsu-Miller
Journal:  Physiol Behav       Date:  2019-02-11

7.  Effects of palatable cafeteria diet on cognitive and noncognitive behaviors and brain neurotrophins' levels in mice.

Authors:  Daniela D Leffa; Samira S Valvassori; Roger B Varela; Jésica Lopes-Borges; Francine Daumann; Luiza M Longaretti; Ana Luiza F Dajori; João Quevedo; Vanessa M Andrade
Journal:  Metab Brain Dis       Date:  2015-05-22       Impact factor: 3.584

Review 8.  Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders.

Authors:  Rita Barandas; Dominic Landgraf; Michael J McCarthy; David K Welsh
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 9.  Diabetes, Depression, and Cognition: a Recursive Cycle of Cognitive Dysfunction and Glycemic Dysregulation.

Authors:  Sheila Black; Kyle Kraemer; Avani Shah; Gaynell Simpson; Forrest Scogin; Annie Smith
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

10.  Plasma vitamin D status and recurrent depressive symptoms in the French SU.VI.MAX cohort.

Authors:  Caroline Collin; Karen E Assmann; Mélanie Deschasaux; Valentina A Andreeva; Cédric Lemogne; Nathalie Charnaux; Angela Sutton; Serge Hercberg; Pilar Galan; Mathilde Touvier; Emmanuelle Kesse-Guyot
Journal:  Eur J Nutr       Date:  2016-07-27       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.